Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone
Background: In the era of novel agents such as lenalidomide and bortezomib, risk stratification by chromosomal abnormalities may enable a more rational selection of therapeutic approaches in patients with multiple myeloma (MM). Methods: The authors analyzed the prognostic value of deletion del(13q14...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2011
|
| In: |
Cancer
Year: 2011, Jahrgang: 117, Heft: 10, Pages: 2136-2144 |
| ISSN: | 1097-0142 |
| DOI: | 10.1002/cncr.25775 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/cncr.25775 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.25775 
|
| Verfasserangaben: | Ulrike Klein, Anna Jauch, Thomas Hielscher, Jens Hillengass, Marc S. Raab, Anja Seckinger, Dirk Hose, Anthony D. Ho, Hartmut Goldschmidt, and Kai Neben |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1814688935 | ||
| 003 | DE-627 | ||
| 005 | 20230710121729.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220818s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cncr.25775 |2 doi | |
| 035 | |a (DE-627)1814688935 | ||
| 035 | |a (DE-599)KXP1814688935 | ||
| 035 | |a (OCoLC)1389793143 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Klein, Ulrike |d 1972- |e VerfasserIn |0 (DE-588)124868800 |0 (DE-627)36723338X |0 (DE-576)294543015 |4 aut | |
| 245 | 1 | 0 | |a Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone |c Ulrike Klein, Anna Jauch, Thomas Hielscher, Jens Hillengass, Marc S. Raab, Anja Seckinger, Dirk Hose, Anthony D. Ho, Hartmut Goldschmidt, and Kai Neben |
| 246 | 3 | 0 | |a plus 1q21 |
| 264 | 1 | |c 2011 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online December 3, 2010 | ||
| 500 | |a Gesehen am 18.08.2022 | ||
| 520 | |a Background: In the era of novel agents such as lenalidomide and bortezomib, risk stratification by chromosomal abnormalities may enable a more rational selection of therapeutic approaches in patients with multiple myeloma (MM). Methods: The authors analyzed the prognostic value of deletion del(13q14), del(17p13), +1q21, translocation t(4;14), t(11;14), and t(14;16) by fluorescence in situ hybridization (FISH) in a series of 92 patients with recurrent MM who were treated with lenalidomide and dexamethasone (len/dex) at the study center. Results: Patients carrying del(13q14) or t(14;16) were found to have a shorter median time to disease progression (TTP) of 5.1 months (vs 14.4 months; P = .009) and 2.0 months (vs 10.5 months; P <.001), respectively. However, no effect on TTP was observed in patients harboring del(13q14) as an exclusive chromosomal aberration without the concomitant presence of t(4;14) or del(17p13). The median overall survival (OS) for patients with del(17p13) or +1q21 was 6.7 months (P = .002) and 8.3 months (P < .001), respectively, whereas the median OS for patients carrying none of these abnormalities was not reached. Multivariate analysis revealed that the effects of del(17p13) and +1q21 on OS were independent of patient age as well as the type and number of regimens administered before len/dex. Conclusions: The results of the current study suggest that the prognostic significance of t(4;14) may be ameliorated or eliminated in patients treated with len/dex, whereas the presence of del(17p13) or +1q21 is still associated with a dismal OS. The presence of t(11;14) and del(13q14) as exclusive chromosomal aberrations indicates no impact on outcome. Because of its rarity in MM, a confirmation of the prognostic role of the t(14;16) aberration is still pending. | ||
| 650 | 4 | |a cytogenetics | |
| 650 | 4 | |a lenalidomide | |
| 650 | 4 | |a multiple myeloma | |
| 650 | 4 | |a overall survival | |
| 700 | 1 | |a Jauch, Anna |d 1959- |e VerfasserIn |0 (DE-588)1025525140 |0 (DE-627)722525362 |0 (DE-576)168357496 |4 aut | |
| 700 | 1 | |a Hielscher, Thomas |e VerfasserIn |0 (DE-588)1159594791 |0 (DE-627)1022977768 |0 (DE-576)50506068X |4 aut | |
| 700 | 1 | |a Hillengaß, Jens |d 1974- |e VerfasserIn |0 (DE-588)124918549 |0 (DE-627)368073823 |0 (DE-576)294568298 |4 aut | |
| 700 | 1 | |a Raab, Marc-Steffen |d 1973- |e VerfasserIn |0 (DE-588)124052460 |0 (DE-627)706520998 |0 (DE-576)293998027 |4 aut | |
| 700 | 1 | |a Seckinger, Anja |d 1980- |e VerfasserIn |0 (DE-588)134177371 |0 (DE-627)562118225 |0 (DE-576)278603734 |4 aut | |
| 700 | 1 | |a Hose, Dirk |d 1969- |e VerfasserIn |0 (DE-588)139824995 |0 (DE-627)613790308 |0 (DE-576)313431698 |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Neben, Kai |d 1969- |e VerfasserIn |0 (DE-588)120842181 |0 (DE-627)080920470 |0 (DE-576)292411774 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer |d New York, NY : Wiley-Liss, 1948 |g 117(2011), 10, Seite 2136-2144 |h Online-Ressource |w (DE-627)271350334 |w (DE-600)1479932-7 |w (DE-576)078590884 |x 1097-0142 |7 nnas |a Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone |
| 773 | 1 | 8 | |g volume:117 |g year:2011 |g number:10 |g pages:2136-2144 |g extent:9 |a Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone |
| 856 | 4 | 0 | |u https://doi.org/10.1002/cncr.25775 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.25775 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220818 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 120842181 |a Neben, Kai |m 120842181:Neben, Kai |d 50000 |e 50000PN120842181 |k 0/50000/ |p 10 |y j | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |d 50000 |e 910000PG102258023X |e 910100PG102258023X |e 50000PG102258023X |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 9 | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 998 | |g 139824995 |a Hose, Dirk |m 139824995:Hose, Dirk |d 910000 |d 910100 |e 910000PH139824995 |e 910100PH139824995 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 134177371 |a Seckinger, Anja |m 134177371:Seckinger, Anja |d 910000 |d 910100 |e 910000PS134177371 |e 910100PS134177371 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 124052460 |a Raab, Marc-Steffen |m 124052460:Raab, Marc-Steffen |d 910000 |d 910100 |e 910000PR124052460 |e 910100PR124052460 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 124918549 |a Hillengaß, Jens |m 124918549:Hillengaß, Jens |d 910000 |d 910100 |e 910000PH124918549 |e 910100PH124918549 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1159594791 |a Hielscher, Thomas |m 1159594791:Hielscher, Thomas |d 140000 |e 140000PH1159594791 |k 0/140000/ |p 3 | ||
| 998 | |g 1025525140 |a Jauch, Anna |m 1025525140:Jauch, Anna |d 910000 |d 910500 |d 50000 |e 910000PJ1025525140 |e 910500PJ1025525140 |e 50000PJ1025525140 |k 0/910000/ |k 1/910000/910500/ |k 0/50000/ |p 2 | ||
| 998 | |g 124868800 |a Klein, Ulrike |m 124868800:Klein, Ulrike |d 910000 |d 910500 |e 910000PK124868800 |e 910500PK124868800 |k 0/910000/ |k 1/910000/910500/ |p 1 |x j | ||
| 999 | |a KXP-PPN1814688935 |e 4180877775 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"display":"Klein, Ulrike","family":"Klein","given":"Ulrike","role":"aut"},{"family":"Jauch","display":"Jauch, Anna","role":"aut","given":"Anna"},{"given":"Thomas","role":"aut","display":"Hielscher, Thomas","family":"Hielscher"},{"display":"Hillengaß, Jens","family":"Hillengaß","role":"aut","given":"Jens"},{"family":"Raab","display":"Raab, Marc-Steffen","role":"aut","given":"Marc-Steffen"},{"family":"Seckinger","display":"Seckinger, Anja","given":"Anja","role":"aut"},{"given":"Dirk","role":"aut","display":"Hose, Dirk","family":"Hose"},{"role":"aut","given":"Anthony Dick","display":"Ho, Anthony Dick","family":"Ho"},{"family":"Goldschmidt","display":"Goldschmidt, Hartmut","role":"aut","given":"Hartmut"},{"given":"Kai","role":"aut","display":"Neben, Kai","family":"Neben"}],"language":["eng"],"note":["Published online December 3, 2010","Gesehen am 18.08.2022"],"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2011"}],"title":[{"title":"Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone","title_sort":"Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Ulrike Klein, Anna Jauch, Thomas Hielscher, Jens Hillengass, Marc S. Raab, Anja Seckinger, Dirk Hose, Anthony D. Ho, Hartmut Goldschmidt, and Kai Neben"]},"physDesc":[{"extent":"9 S."}],"recId":"1814688935","relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"271350334","id":{"eki":["271350334"],"issn":["1097-0142"],"zdb":["1479932-7"],"doi":["10.1002/(ISSN)1097-0142"]},"title":[{"title":"Cancer","title_sort":"Cancer","subtitle":"interdisciplinary international journal of the American Cancer Society"}],"note":["Gesehen am 06.12.2011"],"pubHistory":["1.1948 -"],"origin":[{"publisherPlace":"New York, NY","dateIssuedKey":"1948","publisher":"Wiley-Liss","dateIssuedDisp":"1948-"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasoneCancer","language":["eng"],"titleAlt":[{"title":"Cancer cytopathology"}],"part":{"issue":"10","text":"117(2011), 10, Seite 2136-2144","pages":"2136-2144","year":"2011","volume":"117","extent":"9"}}],"id":{"doi":["10.1002/cncr.25775"],"eki":["1814688935"]}} | ||
| SRT | |a KLEINULRIKCHROMOSOMA2011 | ||